About us
VidaVinci, Inc is a venture-backed, privately held biotech company on a mission to pioneer "a new modality to end all modalities". Our goal is to revolutionize drug discovery at scale, address the toughest challenges of existing modalities, and unlock high-impact therapies for patients. Backed by top tier investors, the Company is co-founded by Drs. Gregory Verdine and Hal Barron--renowned industry leaders known for taking on the most daring scientific challenges. Built on a bold vision to redefine therapeutic innovation, we are pushing the boundaries of what’s possible in medicine. Join us to shape the future of drug discovery.
- Website
-
www.vidavinci.com
External link for VidaVinci, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2024
Employees at VidaVinci, Inc.
-
Patrick Riley
-
Menachem Fromer
Data Science Leader in Biotech; ex-Verily Life Sciences (Google); ex-Broad Institute of MIT & Harvard; Mount Sinai
-
Karen Jarostchuk
Executive Business Partner
-
Matt Hurley
Researcher in Precision Drug Discovery Using Free Energy Calculations / Molecular Dynamics / Machine-Learning